ProQR Therapeutics (PRQR) Current Assets (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Current Assets for 5 consecutive years, with $116.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 29.1% to $116.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $116.6 million through Dec 2025, down 29.1% year-over-year, with the annual reading at $116.6 million for FY2025, 29.1% down from the prior year.
  • Current Assets hit $116.6 million in Q4 2025 for ProQR Therapeutics, down from $164.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $219.1 million in Q4 2021 to a low of $116.6 million in Q4 2025.
  • Historically, Current Assets has averaged $157.6 million across 5 years, with a median of $157.6 million in 2022.
  • Biggest five-year swings in Current Assets: grew 26.29% in 2024 and later dropped 29.1% in 2025.
  • Year by year, Current Assets stood at $219.1 million in 2021, then fell by 28.06% to $157.6 million in 2022, then decreased by 17.4% to $130.2 million in 2023, then increased by 26.29% to $164.4 million in 2024, then decreased by 29.1% to $116.6 million in 2025.
  • Business Quant data shows Current Assets for PRQR at $116.6 million in Q4 2025, $164.4 million in Q4 2024, and $130.2 million in Q4 2023.